Genomic medicine has become a powerful clinical tool in identifying personalized treatments for cancer and in preventing cancers in families with increased genetic risk. Progress in genomic medicine is constantly driven by translational and clinical research, which are vitally dependent on excess tissues and fluids from cancer patients. Collecting and distributing these biospecimens, in an ethically appropriate fashion, are critical aspects of enabling laboratory science and clinical trials.
Miami Cancer Institute’s Center for Genomic Medicine is at the forefront of cancer treatment, prevention and research. With on-site clinical molecular diagnostics, genetic risk assessment and counseling, and a unique collection of biobanked specimens (both retrospective and prospective), our facility is a state-of-the-art clinical and research center with a mission to facilitate a culture of genetic/genomic medicine throughout the Miami Cancer Institute.
The Molecular Diagnostics Laboratory, Division of Clinical Genetics, as well as the Protocol Support Laboratory and Biospecimen Repository Facility, devote their efforts into reducing morbidity and mortality from cancer through precision medicine, primary and secondary prevention, and translational and clinical research support. Our team of Board-certified clinical laboratory specialists, genetic counselors and medical geneticists work closely with our physicians to identify novel, more effective mechanisms for cancer treatment and prevention.
The Center for Genomic Medicine is unmatched in South Florida and places Miami Cancer Institute among an elite group of cancer centers nationwide.
Molecular Diagnostics Lab
The Molecular Diagnostics Laboratory has the most advanced technology to perform molecular tumor profiling, which determines the genetic alterations present in an individual patient’s tumor. This information can reveal valuable data about potential targets for personalized, precision therapies that are most effective in treating a specific type of cancer.
Unlike most cancer centers in the U.S., Miami Cancer Institute’s Molecular Diagnostics Lab is located on site. This means the molecular tumor profiling results can be readily available, giving your doctor the power to make treatment decisions quickly. If your doctor believes additional information is needed about a specific tumor to make an informed decision to create or change a course of treatment, the doctor may order molecular testing. Please talk to your doctor if you would like more information about molecular tumor profiling.
Division of Clinical Genetics
Although we are all at risk of developing cancer, some people have greater-than-average risk for certain cancers because of an inherited genetic condition. Identifying the individuals within families who have an increased genetic risk for cancer will help reduce the likelihood of developing cancer, or help us detect cancer at an early stage when it is more curable.
If you have been diagnosed with cancer or have a family history of cancer, a genetic cancer risk evaluation with the Division of Clinical Genetics may be right for you. Our team of Board-certified genetic counselors and medical geneticists provide individualized genetic risk assessment, genetic testing and counseling services. Our goal is to help you understand how your medical history, family history and genetic test results may play a role in your risk to develop cancer, and empower you, your family and your providers to make more informed decisions regarding cancer prevention.
Biospecimen Repository Facility and Protocol Support Laboratory
The Center for Genomic Medicine’s Biospecimen Repository Facility and Protocol Support Laboratory provide researchers with a wealth of cancer tissues and related materials to conduct laboratory research and clinical trials. Through an in-depth analysis of cancer tissue specimens and blood samples, laboratory and clinical researchers are able to further understand those biological factors that contribute to cancer, which may enable prevention, early detection and more effective therapies. Their work is paving the way for predictive diagnostics and personalized treatment.
If you have been diagnosed with cancer, or you simply wish to make an impact in cancer research, you can provide informed consent to donate excess tissue samples and/or blood to the Biospecimen Repository Facility program. If you are enrolled in a cancer clinical trial, your excess tissues and blood samples collected by the Protocol Support Laboratory will be used to help inform the biological basis of novel therapies. In either case, you will be helping scientists perform groundbreaking research to develop new screening strategies, diagnostic tools and new, more effective cancer therapies.
If you feel you may benefit from genetic and genomic testing, talk to your doctor.